Cimiracemoside D
Cimiracemoside D is a bioactive triterpene glycoside isolated from the medicinal plant Cimicifuga foetida L. Research indicates it exhibits anti-inflammatory and anti-osteoporotic activities, making it a compound of interest for pharmacological studies in both cellular and animal models.
Product Specifications
CAS Number
290821-39-5
Product Name Alternative
Cimiracemoside D, inhibit, Inhibitor
Purity
99.66% (May vary between batches)
Solubility
DMSO:10 mg/mL (14.73 mM) ;10% DMSO+40% PEG300+5% Tween-80+45% Saline:0.5 mg/mL (0.74 mM)
Smiles
[H][C@@]12C[C@@H] (C) [C@@]3 ([H]) C (O[C@@H]1C (C) (C) O) (O2) [C@H] (O) [C@@]1 (C) [C@]2 ([H]) CC[C@]4 ([H]) [C@]5 (C[C@@]25C[C@@H] (OC (C) =O) [C@]31C) CC[C@H] (O[C@]1 ([H]) OC[C@H] (O) [C@H] (O) [C@H]1O) C4 (C) C
Molecular Formula
C37H58O11
Molecular Weight
678.85
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6395164-01 0.1 mL
SSX2IP (Synovial Sarcoma X Breakpoint 2 Interacting Protein, SSX2-interacting Protein, Afadin and alpha Actinin Binding Protein, Afadin DIL Domain Interacting Protein, Afadin-and alpha-actinin-binding Protein, ADIP, FLJ10848, KIAA0923, MGC75026) (MaxLight
Sign In for Pricing
View Details MBS6395164-02 5x 0.1 mL
SSX2IP (Synovial Sarcoma X Breakpoint 2 Interacting Protein, SSX2-interacting Protein, Afadin and alpha Actinin Binding Protein, Afadin DIL Domain Interacting Protein, Afadin-and alpha-actinin-binding Protein, ADIP, FLJ10848, KIAA0923, MGC75026) (MaxLight
Sign In for Pricing
View Details 